MLYS

Mineralys Therapeutics, Inc. Common Stock
Data: 2026-04-01
$26.41
Price
-2.51%
Change
$47.65
52W High
$10.44
52W Low

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Quick Stats
Apr 01, 2026

59.9

AI Score

HOLD

0.83

Volume Ratio

May 11, 2026

Next Earnings

12

+ve Days (30d)

18

-ve Days (30d)

MLYS Stock Summary

Last updated Apr 01, 2026

MLYS is currently trading at $26.41, positioned below its 200-day moving average of $29.54, suggesting bearish momentum. The stock has a 52-week range of $10.44 to $47.65.

Technical Analysis: The 50-day moving average stands at $28.22, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 50.88, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.076, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates MLYS at 59.9/100 with a HOLD recommendation.

MLYS (Mineralys Therapeutics, Inc. Common Stock) Indicators

Last updated Apr 01, 2026

Indicator Value
RSI(14) 50.88
CMF (20) -0.076
ROC (10) 10.502
ADX (14) 21.801
Indicator Value
MACD (12,26,9) -1.022
AROONOSC (14) 42.857
WILLAMS %R (14) -40.225
MFI (14) 49.766
MLYS Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

MLYS Price vs Max Options Open Interest
MLYS Max Change In Options Open Interest

MLYS Options - Sort by Max open Interest (near term)

2nd April 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

MLYS Daily Out of Money Options - Sort by Max open Interest (near term)

2nd April 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

MLYS Daily In the Money Options - Sort by Max open Interest (near term)

2nd April 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

MLYS Most Active Options by Volume(near term)

2nd April 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Mineralys Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

MLYS Moving Averages Analysis

MLYS (Mineralys Therapeutics, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Apr 01, 2026

Days MA
10 24.28
20 25.38
30 26.55
50 28.22
100 33.24
200 29.54

MLYS Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 2.2 billion
Earnings/Share ($) -2.29
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -2.0957
EPS Estimate Next Year ($) -1.83
WallStreet Target Price ($) 49.375
Most Recent Quarter